Brain Cancer RTOG 0913

March 13, 2013

Location: The Hospital of Central Connecticut

Phase I/II Trial of Concurrent RAD001 (Everolimus) with Temozolomide/Radiation Followed by Adjuvant RAD001/Temozolomide in Newly Diagnosed Glioblastoma.